Home > Insider Trading > Acadia Pharmaceuticals Inc

Acadia Pharmaceuticals Inc (ACAD)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Billionaire Steve Cohen and Insiders are Buying These 5 Stocks

This article presents an overview of Billionaire Steve Cohen and Insiders are Buying These 5 Stocks. For a detailed overview of such stocks, read our article, Billionaire Steve Cohen and Insiders ...

Keep Reading →

March 20th, 2024 - Insider Trading News

5 Oversold Biotech Stocks To Buy Right Now

In this article, we will be taking a look at 5 oversold biotech stocks to buy right now.

Keep Reading →

March 17th, 2024 - Hedge Funds News

5 Oversold NASDAQ Stocks To Buy Right Now

In this article, we will be taking a look at 5 oversold NASDAQ stocks to buy right now.

Keep Reading →

March 13th, 2024 - Hedge Funds News

5 Oversold Healthcare Stocks To Buy Right Now

In this article, we will be taking a look at 5 oversold healthcare stocks to buy right now.

Keep Reading →

March 13th, 2024 - News

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2023 Earnings Call Transcript

ACADIA Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.28 EPS, expectations were $0.32. ACADIA Pharmaceuticals Inc.

Keep Reading →

February 29th, 2024 - News Transcripts

Best Drug and Alcohol Rehab Centers in Each of 30 Biggest Cities in the US

In this article, we take a look at the Best Drug and Alcohol Rehab Centers in Each of the 30 Biggest Cities in the US.

Keep Reading →

January 26th, 2024 - Lists News

10 Stocks Receiving a Massive Vote of Approval From Wall Street Analysts

In this article, we will take a look at the 10 stocks receiving a massive vote of approval from Wall Street analysts.

Keep Reading →

January 25th, 2024 - Market Movers News

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2023 Earnings Call Transcript

Operator: Good day ladies and gentlemen and welcome to ACADIA Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. My name is Kathy and I will be your coordinator for today.

Keep Reading →

November 4th, 2023 - News Transcripts